{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:49:33Z","timestamp":1791902973659,"version":"4.3.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Allergic rhinitis is an inflammatory disorder associated with local leukotriene release during periods of symptoms. Therefore, it has been suggested that antileukotrienes may be beneficial in the treatment of this disease. Leukotriene receptor antagonists have recently become available for asthma treatment, but little is known of their effects on allergic rhinitis. We have evaluated the effects of the leukotriene receptor antagonist zafirlukast versus placebo in patients with allergic rhinitis during the grass pollen season, using the nasal glucocorticoid beclomethasone dipropionate (BDP) as a positive treatment control. Thirty-three patients with seasonal allergic rhinitis were in a double-blind, double-dummy fashion randomized to treatments with oral zafirlukast (20 mg twice a day), intranasal beclomethasone dipropionate (200 \u03bc g twice a day), or placebo. The treatment was initiated 3 wk prior to the expected beginning of the grass pollen season. Patients completed a daily symptom-score list for sneezing, rhinorrhea, nasal itch, and nasal blockage during the 50-d treatment period. Nasal biopsies for quantification of local tissue eosinophilia (immunohistochemistry; EG2) were taken 1 mo before initiation of treatment and immediately after the peak of grass pollen season. Patients receiving treatment with zafirlukast had degrees of nasal symptoms similar to those in the placebo group, whereas the BDP group had significantly less symptoms compared with both treatments (p = 0.01 and p = 0.005, respectively). The numbers of activated eosinophils in the nasal tissue increased significantly during the pollen season in both the zafirlukast and the placebo groups, but not in the BDP group. These results obtained with a limited number of patients do not support any clinical efficacy of regular treatment with an oral antileukotriene in seasonal allergic rhinitis but rather favor the use of a nasal glucocorticoid.<\/jats:p>","DOI":"10.1164\/ajrccm.159.6.9810016","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T13:59:16Z","timestamp":1365083956000},"page":"1814-1818","source":"Crossref","is-referenced-by-count":82,"title":["Randomized Placebo-controlled Study Comparing a Leukotriene Receptor Antagonist and a Nasal Glucocorticoid in Seasonal Allergic Rhinitis"],"prefix":"10.1093","volume":"159","author":[{"given":"TEET","family":"PULLERITS","sequence":"first","affiliation":[{"name":"Lung Pharmacology Group, Department of Respiratory Medicine and Allergology, Institute of Heart and Lung Diseases, G\u00f6teborg University, Gothenburg, Sweden; Lung and Otorhinolaryngology Clinic, University of Tartu, Tartu, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LEA","family":"PRAKS","sequence":"additional","affiliation":[{"name":"Lung Pharmacology Group, Department of Respiratory Medicine and Allergology, Institute of Heart and Lung Diseases, G\u00f6teborg University, Gothenburg, Sweden; Lung and Otorhinolaryngology Clinic, University of Tartu, Tartu, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BENGT-ERIC","family":"SKOOGH","sequence":"additional","affiliation":[{"name":"Lung Pharmacology Group, Department of Respiratory Medicine and Allergology, Institute of Heart and Lung Diseases, G\u00f6teborg University, Gothenburg, Sweden; Lung and Otorhinolaryngology Clinic, University of Tartu, Tartu, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAIVO","family":"ANI","sequence":"additional","affiliation":[{"name":"Lung Pharmacology Group, Department of Respiratory Medicine and Allergology, Institute of Heart and Lung Diseases, G\u00f6teborg University, Gothenburg, Sweden; Lung and Otorhinolaryngology Clinic, University of Tartu, Tartu, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAN","family":"L\u00d6TVALL","sequence":"additional","affiliation":[{"name":"Lung Pharmacology Group, Department of Respiratory Medicine and Allergology, Institute of Heart and Lung Diseases, G\u00f6teborg University, Gothenburg, Sweden; Lung and Otorhinolaryngology Clinic, University of Tartu, Tartu, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1999,6,1]]},"reference":[{"key":"2026032709001667100_B1","first-page":"1392","article-title":"Seasonal allergic rhinitis.","volume":"314","author":"Parikh","year":"1997","journal-title":"B.M.J."},{"key":"2026032709001667100_B2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/ajrccm\/138.2.406","article-title":"The influx of inflammatory cells into nasal washings during the late response to antigen challenge: effect of systemic steroid pretreatment.","volume":"138","author":"Bascom","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709001667100_B3","doi-asserted-by":"crossref","first-page":"S763","DOI":"10.1016\/S0091-6749(97)70125-8","article-title":"Pathogenesis of allergic rhinitis.","volume":"99","author":"Baraniuk","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709001667100_B4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1164\/ajrccm\/136.2.357","article-title":"Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis.","volume":"136","author":"Miadonna","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709001667100_B5","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJM198406213102502","article-title":"Peptide leukotriene release after antigen challenge in patients sensitive to ragweed.","volume":"310","author":"Creticos","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"2026032709001667100_B6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2222.1986.tb01960.x","article-title":"Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans.","volume":"60","author":"Bisgaard","year":"1986","journal-title":"Clin. Allergy"},{"key":"2026032709001667100_B7","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199012203232506","article-title":"Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor.","volume":"323","author":"Knapp","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"2026032709001667100_B8","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1164\/ajrccm.151.6.7767514","article-title":"The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis.","volume":"151","author":"Donnelly","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032709001667100_B9","first-page":"S443","article-title":"Pranlukast (UltairTM, SB 205312, ONO-1078), an oral leukotriene receptor antagonist, relieves symptoms in patients with seasonal allergic rhinitis (SAR) (abstract).","volume":"99","author":"Grossman","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709001667100_B10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/019459989010200303","article-title":"The effect of a leukotriene antagonist on the early response to antigen.","volume":"102","author":"Flowers","year":"1990","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"2026032709001667100_B11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0091-6749(89)90075-4","article-title":"Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis.","volume":"83","author":"Juniper","year":"1989","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709001667100_B12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0140-6736(93)91073-U","article-title":"Leukotriene E4 and granulocytic infiltration into asthmatic airways.","volume":"341","author":"Laitinen","year":"1993","journal-title":"Lancet"},{"key":"2026032709001667100_B13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/0091-6749(86)90384-2","article-title":"Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosol.","volume":"77","author":"Orgel","year":"1986","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709001667100_B14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2222.1991.tb03199.x","article-title":"Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season.","volume":"21","author":"Klementsson","year":"1991","journal-title":"Clin. Exp. Allergy"},{"key":"2026032709001667100_B15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0091-6749(92)90217-P","article-title":"Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract.","volume":"89","author":"Lozewicz","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709001667100_B16","first-page":"165","article-title":"Two-dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis.","volume":"21","author":"Nuutinen","year":"1983","journal-title":"Rhinology"},{"key":"2026032709001667100_B17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1164\/ajrccm.150.3.8087328","article-title":"Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma.","volume":"150","author":"Spector","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032709001667100_B18","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0091-6749(90)90080-N","article-title":"Lack of suppression of IgE production by recombinant interferon gamma: a controlled trial in patients with allergic rhinitis.","volume":"85","author":"Li","year":"1990","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709001667100_B19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/309182a0","article-title":"Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein.","volume":"309","author":"Tai","year":"1984","journal-title":"Nature"},{"key":"2026032709001667100_B20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0025-6196(12)61882-5","article-title":"Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy.","volume":"62","author":"Welsh","year":"1987","journal-title":"Mayo Clin. Proc."},{"key":"2026032709001667100_B21","first-page":"309","article-title":"Budesonide in grass pollen rhinitis.","volume":"69","author":"Norman","year":"1992","journal-title":"Ann. Allergy"},{"key":"2026032709001667100_B22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1398-9995.1986.tb02023.x","article-title":"Pollen seasons: forecasts of the most important allergenic plants in Finland.","volume":"41","author":"Koivikko","year":"1986","journal-title":"Allergy"},{"key":"2026032709001667100_B23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2222.1976.tb01412.x","article-title":"City spore concentrations in the European Economic Community (EEC) I. Grass pollen, 1973.","volume":"6","author":"Bagni","year":"1976","journal-title":"Clin. Allergy"},{"key":"2026032709001667100_B24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0091-6749(92)90444-7","article-title":"Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells.","volume":"89","author":"Bentley","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709001667100_B25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1164\/ajrccm\/142.4.863","article-title":"Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry.","volume":"142","author":"Djukanovic","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709001667100_B26","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1164\/ajrccm.157.5.9609014","article-title":"Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.","volume":"157","author":"Calhoun","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032709001667100_B27","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1164\/ajrccm.154.4.8887574","article-title":"Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig.","volume":"154","author":"Underwood","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032709001667100_B28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2222.1996.tb00621.x","article-title":"The role of leukotrienes in asthma and allergic rhinitis.","volume":"26","author":"Busse","year":"1996","journal-title":"Clin. Exp. Allergy"},{"key":"2026032709001667100_B29","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1378\/chest.111.2_Supplement.11S","article-title":"One airway, one disease.","volume":"111","author":"Grossman","year":"1997","journal-title":"Chest"},{"key":"2026032709001667100_B30","first-page":"228","article-title":"Generation of leukotriene B4 and C4 from granulocytes of normal controls, allergic rhinitis, and asthmatic subjects.","volume":"65","author":"Kohi","year":"1990","journal-title":"Ann. Allergy"},{"key":"2026032709001667100_B31","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/BF02484433","article-title":"Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients.","volume":"1","author":"Wang","year":"1995","journal-title":"Eur. Arch. Otorhinolaryngol. Suppl."},{"key":"2026032709001667100_B32","first-page":"537","article-title":"The role of leukotriene D4 in allergic rhinitis.","volume":"60","author":"Okuda","year":"1988","journal-title":"Ann. Allergy"},{"key":"2026032709001667100_B33","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1164\/ajrccm\/143.5_Pt_2.S96","article-title":"The potential role of leukotrienes in bronchial asthma.","volume":"143","author":"Piacentini","year":"1991","journal-title":"Am. Rev. Respir. Dis."}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/159\/6\/1814\/67429517\/ajrccm_159_6_1814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/159\/6\/1814\/67429517\/ajrccm_159_6_1814.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:00:27Z","timestamp":1774616427000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/159\/6\/1814\/8530017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6,1]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,6,1]]},"published-print":{"date-parts":[[1999,6,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.159.6.9810016","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,6]]},"published":{"date-parts":[[1999,6,1]]}}}